Back to search
FDAFDA · Food and drugs·Recall number D-0672-2017

CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL), Valeant Pharmaceuticals North America LLC Distributed by OMP, Inc Long Beach, CA 90806 Made in USA. Product SKU 301876102042, NDC 0187-6102-04

Published April 26, 2017 · Recall initiated: March 20, 2017

Summary

FDA records drug Class III recall D-0672-2017, published April 26, 2017 and initiated March 20, 2017. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 38,767 units; Lot: Lot #: 15J1277, Exp. 04/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Valeant Pharmaceuticals North America LLC
Distributor
nationwide
Lot
Lot #: 15J1277, Exp. 04/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL), Valeant Pharmaceuticals North America LLC Distributed by OMP, Inc Long Beach, CA 90806 Made in USA. Product SKU 301876102042, NDC 0187-6102-04 recalled?

Yes. FDA published recall D-0672-2017 on April 26, 2017. Reported hazard: Discoloration.

What should I do if I have this product?

Voluntary: Firm initiated · Letter